Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 95.91M P/E - EPS this Y 52.60% Ern Qtrly Grth -
Income -93.61M Forward P/E -1.20 EPS next Y 8.00% 50D Avg Chg 5.00%
Sales - PEG -0.08 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 1.05 EPS next 5Y 15.50% 52W High Chg -82.00%
Recommedations 1.70 Quick Ratio 1.99 Shares Outstanding 89.93M 52W Low Chg 95.00%
Insider Own 7.72% ROA -68.13% Shares Float 49.38M Beta 1.96
Inst Own 58.07% ROE -131.28% Shares Shorted/Prior 2.47M/2.52M Price 2.16
Gross Margin - Profit Margin - Avg. Volume 1,094,725 Target Price 11.88
Oper. Margin - Earnings Date May 9 Volume 510,613 Change -7.30%
About Immunic, Inc.

Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical trial, for treatment of multiple sclerosis, including relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is also developing IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.

Immunic, Inc. News
03/21/24 Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
03/21/24 Immunic secures key patent, boosting MS drug exclusivity and global IP strategy
03/20/24 Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
03/08/24 Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
03/07/24 Immunic to Participate in Investor and Scientific Conferences in March
06:30 AM Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
02/23/24 Immunic Inc (IMUX) Reports Year-End 2023 Financial Results
02/23/24 Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
02/22/24 Immunic reports successful 2023 and prepares for key 2025 milestones
02/22/24 Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
02/15/24 Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update
02/01/24 Immunic to Participate in Investor and Scientific Conferences in February
01/05/24 Immunic Highlights 2023 Accomplishments and Upcoming Milestones
01/05/24 Immunic, Inc. Announces Private Placement of up to $240 Million
11/21/23 Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis
11/14/23 Immunic focusing on business development during Q4
11/14/23 Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
11/07/23 Immunic to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide Corporate Update
11/02/23 Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts
10/26/23 Immunic to Participate in Scientific and Industry Conferences in November
IMUX Chatroom

User Image WaltonInvestment Posted - 23 hours ago

$IMUX

User Image Soldad0Blanc0 Posted - 23 hours ago

$IMUX this is the one that needs to Run!

User Image Jw242 Posted - 1 day ago

$IMUX hello $1 incoming

User Image ErnieWorthing84 Posted - 3 days ago

$IMUX https://twitter.com/ImmunicInc/status/1772609452182819300

User Image Jw242 Posted - 3 days ago

$IMUX ever since jackpro and his minions left we’ve tanked. Stay clear of his BS

User Image takingstock73 Posted - 4 days ago

$IMUX hope soon is this week

User Image Soldad0Blanc0 Posted - 1 week ago

$IMUX this will rip soon.

User Image Kzixo Posted - 1 week ago

$PRZO $IMUX $UP $LAES $SMMT the new shorting people strategy , raise the stock suddenly in 10 minutes !! People buy next day short it heavily!!! The market is changing to SHORTING MARKET

User Image taxidriver514 Posted - 1 week ago

$IMUX https://www.youtube.com/watch?v=NR-OXEw7DOA&t=4s

User Image Jw242 Posted - 1 week ago

$IMUX green markets at open - no bueno here

User Image marvessa Posted - 1 week ago

$IMUX when is the year of this share ? 2025 ?

User Image RocketCityChick Posted - 1 week ago

$IMUX

User Image jn1520 Posted - 1 week ago

$IMUX imo Aubagio had sales of 2 billion sales for MS and least effective…imux drug appears to be more targeted in MS…jmho

User Image Kzixo Posted - 1 week ago

$IMUX I think this going to enter the 2.5 $ soon inshalla

User Image John_D_Stockefeller Posted - 1 week ago

$IMUX Why is it that any rise in price on any stock is called a “pump”? Used to be that a stock would simply go upon demand after good news, or good earnings.

User Image Share54321 Posted - 1 week ago

$IMUX why now patent pump?

User Image Jw242 Posted - 1 week ago

$IMUX patent pump!

User Image ILikeCookies2 Posted - 1 week ago

$IMUX Why does this stock always dump on positive news?

User Image Jw242 Posted - 1 week ago

$IMUX PR here is death

User Image OpenOutcrier Posted - 1 week ago

$IMUX (+4.5% pre) Immunic Inc. (IMUX) Receives US Patent of a Specific Polymorph of Vidofludimus Calcium - SI https://ooc.bz/l/28160

User Image Stock_Titan Posted - 1 week ago

$IMUX Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States https://www.stocktitan.net/news/IMUX/immunic-receives-notice-of-allowance-for-composition-of-matter-uthffk381hk8.html

User Image Joeeeejoeeeeeey Posted - 1 week ago

$FUSN next buyout will be $IMUX

User Image springi Posted - 1 week ago

$FUSN next buyout is $IMUX

User Image village1 Posted - 1 week ago

$IMUX it's sickening how market markers and shorts can continue to take any gains daily back to zero by the end of the day. Ahhh, life on the smaller cap stocks in todays stock market, just allowed and never even looked at. Must be nice!

User Image Spiv_0 Posted - 1 week ago

$IMUX been following for years, got in today with a first batch. Downside risk seems small now vs upside potential. I like flatlining bottoms.

User Image Soldad0Blanc0 Posted - 1 week ago

$IMUX let’s get more volume!

User Image ErnieWorthing84 Posted - 1 week ago

$IMUX https://www.youtube.com/watch?v=uJfFJam2WT8&t=4s

User Image Frizby Posted - 1 week ago

$IMUX 2.5 million volume?? Wow!

User Image coujatrader Posted - 2 weeks ago

$IMUX more buys at a 1.00? Please?!

User Image coujatrader Posted - 2 weeks ago

$IMUX anyone not in this for the long is fooling themselves

Analyst Ratings
Wedbush Outperform Oct 10, 23
Wedbush Outperform Jul 27, 23
SVB Leerink Market Perform Oct 21, 22
Aegis Capital Buy Aug 8, 22
SVB Leerink Outperform Jun 3, 22
Piper Sandler Overweight May 18, 22
HC Wainwright & Co. Buy Sep 7, 21
Aegis Capital Buy Apr 15, 21
JMP Securities Market Outperform Mar 24, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Whaley Glenn Chief Financial Offi.. Chief Financial Officer May 15 Buy 1.75 5,000 8,750 25,510 05/16/23
Neermann Joerg Director Director Nov 23 Buy 1.39 18,000 25,020 18,000 11/25/22
Vitt Daniel President and CEO President and CEO Nov 22 Buy 1.3499 8,000 10,799 376,877 11/23/22
Whaley Glenn Chief Financial Offi.. Chief Financial Officer Nov 07 Buy 1.495 5,000 7,475 20,510 11/08/22
Vitt Daniel President and CEO President and CEO Jun 03 Buy 3.0999 5,000 15,500 368,877 06/06/22
Whaley Glenn Chief Financial Offi.. Chief Financial Officer Jun 03 Buy 3.045 3,500 10,658 12,568 06/06/22
Muehler Andreas Chief Medical Office.. Chief Medical Officer May 12 Buy 5.10 3,500 17,850 297,986 05/16/22